Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Price & Analysis

Compare

0 Followers

AGARWALEYE Stock Chart & Stats

₹500.00

Market closed

₹500.00

Day’s Range― - ―

52-Week Range₹327.40 - ₹567.80

Previous CloseN/A

VolumeN/A

Average Volume (3M)13.83K

Market Cap

₹133.68B

Enterprise Value₹142.21B

Total Cash (Recent Filing)₹3.97B

Total Debt (Recent Filing)₹9.83B

Price to Earnings (P/E)118.8

Beta0.56

Next Earnings

Jun 03, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.10

Shares Outstanding316,807,500

10 Day Avg. Volume7,500

30 Day Avg. Volume13,832

Financial Highlights & Ratios

PEG Ratio43.43

Price to Book (P/B)7.19

Price to Sales (P/S)7.85

P/FCF Ratio589.13

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)4.02

Revenue Forecast (FY)₹20.63B

Bulls Say, Bears Say

Bulls Say

Revenue & Margin ExpansionConsistent multi-year revenue and margin expansion reflects durable demand for ophthalmic services and effective cost management. This trend indicates sustainable operating leverage as volumes scale, supporting continued profitability improvement and capacity to reinvest in facilities and specialty services over the medium term.

Cash GenerationSteady operating cash flow and rising free cash flow underpin the firm's ability to fund working capital, service debt, and invest in network expansion without frequent equity raises. Reliable cash generation supports medium-term resilience, predictable reinvestment and funding for strategic initiatives.

Equity Base & ROEA growing shareholders' equity base alongside improved ROE signals effective capital deployment and a stronger cushion against shocks. This healthier equity position provides financial flexibility for organic expansion and strategic investment while supporting credibility with lenders and stakeholders over the next several months.

Bears Say

Leverage RiskModerately high leverage raises interest and refinancing vulnerability, making cash flows more sensitive to rate moves or volume declines. Continued reliance on debt can constrain strategic flexibility, increase financing costs, and pressure free cash flow generation if surgical volumes or reimbursements weaken.

Profitability VolatilityVolatile net margins reduce earnings predictability and complicate capital-allocation decisions. If margins swing due to variable operating expenses, consumable costs, or financing items, free cash flow and the ability to sustain investments in network expansion and specialized services may be impaired.

Execution & Disclosure GapsReliance on opening centers and increasing patient footfall creates execution risk, and the absence of disclosed center counts and payer-mix details limits transparency. These disclosure gaps make it harder to assess scalability, same-store growth, and sensitivity to reimbursement trends over the medium term.

Dr. Agarwal's Health Care Ltd. News

Dr. Agarwal’s Health Care Grants 4.44 Lakh ESOPs Under 2022 Scheme

The latest announcement is out from Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ). Dr. Agarwal’s Health Care...

1M ago

Dr. Agarwal’s Health Care Gets Clean Monitoring Report on IPO Proceeds Utilisation

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an announcement. Dr. Agarwal’s Health Care Limited has...

1M ago

Dr. Agarwal’s Health Care Sets Board Meet and Analyst Call for Q3 FY26 Results

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has shared an update. Dr. Agarwal’s Health Care Limited has...

2M ago

Dr. Agarwal’s Health Care Announces Equity Share Allotment to Employees

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an update. Dr. Agarwal’s Health Care Limited has...

3M ago

Dr. Agarwal’s Health Care Ltd. Expands Employee Stock Options

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) just unveiled an update. Dr. Agarwal’s Health Care Ltd. announced...

5M ago

Dr. Agarwal’s Health Care Ltd. Confirms Proper Utilization of IPO Proceeds

The latest update is out from Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ). Dr. Agarwal’s Health Care...

5M ago

Dr. Agarwal’s Health Care Expands Stake in Eye Hospital Subsidiary

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an announcement. Dr. Agarwal’s Health Care Ltd. has...

6M ago

Dr. Agarwal’s Health Care and Eye Hospital Announce Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has shared an announcement. Dr. Agarwal’s Health Care Limited and...

7M ago

Dr. Agarwal’s Health Care Announces Analyst Call on Proposed Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an update. Dr. Agarwal’s Health Care Limited has...

7M ago

Dr. Agarwal’s Health Care Ltd. Announces Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an announcement. Dr. Agarwal’s Health Care Ltd. has...

7M ago

AGARWALEYE FAQ

What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?

Dr. Agarwal's Health Care Ltd. lowest stock price was ₹327.40 and its highest was ₹567.80 in the past 12 months.

What is Dr. Agarwal's Health Care Ltd.’s market cap?

Dr. Agarwal's Health Care Ltd.’s market cap is ₹133.68B.

When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?

Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 78 days.

How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?

Dr. Agarwal's Health Care Ltd. released its earnings results on Feb 13, 2026. The company reported ₹1.1 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.1.

Is Dr. Agarwal's Health Care Ltd. overvalued?

According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Dr. Agarwal's Health Care Ltd. pay dividends?

Dr. Agarwal's Health Care Ltd. does not currently pay dividends.

What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?

Dr. Agarwal's Health Care Ltd.’s EPS estimate is 1.

How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?

Dr. Agarwal's Health Care Ltd. has 316,807,500 shares outstanding.

What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?

Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1.1 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -0.84%.

Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?

Currently, no hedge funds are holding shares in IN:AGARWALEYE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.